Continuing education credit is not offered for these on-demand videos which are for informational purposes only. For courses offering continuing education, please checkout our live events or visit our partners at CASAT Learning.
This training is designed for firefighters, EMTs/Paramedics, and law enforcement personnel and includes guidance on how to identify characteristics or behaviors of people with intellectual and/or developmental disabilities (I/DD) and best practices to respond to those individuals.
This video features Dr. Julie Cope, a dual-credentialed nurse practitioner, discussing her experience implementing Medication for Opioid Use Disorder (MOUD) programs in rural and mental health settings. She highlights the integration of MOUD into primary care, the benefits of group-based treatment, and the life-saving impact of collaborative, patient-centered approaches to opioid addiction..
This online video provides a foundational understanding of Medications for Opioid Use Disorder (MOUD), exploring their benefits and applications in treating opioid addiction. Participants will learn about specific medications such as Buprenorphine, Methadone, and Naltrexone, along with strategies to engage clients in treatment discussions and empower informed decision-making.
This presentation provides an overview of recent trends in fatal and non-fatal overdose data in Nevada, with a focus on Washoe County and Northern Nevada.
This one-hour video will provide an overview of emerging opioids and related substances. Providers working in local communities need to be prepared for emerging substances and how they can complicate the response to opioid overdose. The session will begin with a description of opioid trends and emerging substances such as xylazine and nitazines, including mechanisms of action and acute health effects when substances are combined. The presentation will incorporate a discussion on how to implement effective approaches for emerging substances and strategies for overcoming barriers.
This Listening Session shares experiences with fentanyl test strip education and distribution, preparedness for overdose emergencies; the evolution of Harm Reduction, and emerging groups of synthetic opioids.